Tata Chemicals Ltd (TATACHEM) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Tata Chemicals Ltd reported sales of ₹4,255 Cr, operating profit of ₹538 Cr (OPM 13%) and net profit of ₹60 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
TATACHEM quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 3,999 3,590 3,509 3,719 3,877 3,550 3,438 4,255 Expenses 3,381 3,156 3,182 3,070 3,340 3,205 3,164 3,717 Operating Profit 618 434 327 649 537 345 274 538 OPM 15% 12% 9% 17% 14% 10% 8% 13% Other Income 152 -10 29 138 128 21 -1,760 56 Interest 145 148 137 147 144 146 153 148 Depreciation 277 280 293 280 285 293 343 336 Profit before tax 348 -4 -74 360 236 -73 -1,982 110 Tax 23% 425% -34% 12% 35% -5% 7% 45% Net Profit 267 -21 -49 316 154 -69 -2,116 60 EPS in Rs 7.61 -2.08 -2.2 9.89 3.02 -3.65 -83.67 -0.67
TATACHEM profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 12,622 16,789 15,421 14,887 14,584 15,120 Expenses 10,303 12,969 12,574 12,934 12,779 13,426 Operating Profit 2,319 3,820 2,847 1,953 1,805 1,694 OPM 18% 23% 18% 13% 12% 11% Other Income 472 218 -507 287 -1,473 -1,555 Interest 303 406 530 563 590 591 Depreciation 806 892 980 1,123 1,201 1,257 Profit before tax 1,682 2,740 830 554 -1,459 -1,709 Tax 16% 11% 46% 30% 18% - Net Profit 1,405 2,434 435 387 -1,715 -1,971 EPS in Rs 49.36 90.93 10.52 9.22 -74.41 -84.97 Dividend Payout 25% 19% 143% 119% -15% -
TATACHEM balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 255 255 255 - 255 Reserves 19,466 21,986 21,339 - 20,951 Borrowings 6,296 5,563 7,072 - 8,001 Other Liabilities 8,923 8,907 9,084 - 9,791 Total Liabilities 34,940 36,711 37,750 - 38,998 Fixed Assets 17,092 17,861 19,600 - 20,602 CWIP 2,410 2,217 1,913 - 1,038 Investments 7,448 9,739 9,144 - 9,886 Other Assets 7,990 6,894 7,093 - 7,472 Total Assets 34,940 36,711 37,750 - 38,998
TATACHEM cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 1,644 2,971 3,016 1,761 1,269 Cash from Investing Activity -817 -1,149 -605 -1,667 -766 Cash from Financing Activity -755 -2,076 -2,494 29 -670 Net Cash Flow 72 -254 -83 123 -167 Free Cash Flow 379 1,427 1,193 -191 129 CFO/OP 82% 88% 120% 102% 67%
TATACHEM ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 56 57 45 47 52 Inventory Days 317 282 341 324 353 Days Payable 338 289 320 318 293 Cash Conversion Cycle 35 50 66 53 113 Working Capital Days -29 29 -22 -21 -17 ROCE 8% 12% 8% 4% 3%